Kidney Disease Clinical Trials in Houston

Showing 201-220 of 415 trials

VasQ External Support for Arteriovenous Fistula

NCT03242343

This is a prospective clinical study of the VasQ external support for arteriovenous fistulas. The device is designed to improve fistula outcomes by optimizing the geometrical configuration of the fistula, influencing hemodynamics, minimizing turbulence and promote laminar flow. All patients will be implanted with the VasQ device and will be followed up for a duration of 24 months.

Arterio-Venous FistulaESRDSteal Syndrome+5 more

Laminate Medical Technologies144 participantsStarted Nov 2017

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Peoria, Illinois, United States +12 more locations

COMPLETEDPhase 2< 1 mile

Neoadjuvant Sitravatinib in Combination With Nivolumab in Patients With Clear Cell Renal Cell Carcinoma

NCT03680521

The study will evaluate the clinical activity of sitravatinib in combination with nivolumab in patients with locally-advanced clear cell renal cell carcinoma (ccRCC) in the neoadjuvant setting prior to nephrectomy.

Clear Cell Renal Cell Carcinoma

Mirati Therapeutics Inc.25 participantsStarted Oct 2018

Houston, Texas, United States

VasQ External Support for Arteriovenous Fistula

Neoadjuvant Sitravatinib in Combination With Nivolumab in Patients With Clear Cell Renal Cell Carcinoma

Kidney Disease Trials in Other Cities

Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency

A Phase 2 Study of Sitravatinib in Combination With PD-(L)1 Checkpoint Inhibitor Regimens in Patients With Advanced or Metastatic Urothelial Carcinoma

Hemodialysis in the Elderly (70yrs & Older)

A Study to Examine Past Estimated Glomerular Filtration Rate (eGFR) Slope as a Risk Marker for Rapid Kidney Function Decline in People With Chronic Kidney Disease

A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

Look AHEAD: Action for Health in Diabetes

Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney Failure Requiring Regular Hemodialysis

Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma

A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)

Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease

A Study of AND017 to Treat Anemia in Non-dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients

An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants

A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease

High Dose IL 2 and Entinostat in RCC

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal Function

Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis

Other Conditions in Houston